ArticleInternational journal of fertility & sterility2026
The Effect of Intramuscular Human Chorionic Gonadotropin on Endometrial Preparation in Frozen-Thawed Embryo Transfer: A Randomized Clinical Trial.
Article in International journal of fertility & sterility, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04855383 (The Effect of Intramuscular Injection of Triple Doses of Human Chorionic Gonadotropin in Frozen Embryo Transfer Cycles), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
The Effect of Intramuscular Injection of Triple Doses of Human Chorionic Gonadotropin in Frozen Embryo Transfer Cycles
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Experimental evidence suggests that the human endometrium expresses receptors for human chorionic gonadotropin (hCG), and activation of these receptors may enhance embryo implantation. Numerous studies have explored the effects of intrauterine hCG injection on embryo transfer (ET) outcomes; however, the impact of systemic hCG administration has been investigated in comparatively fewer studies. This study aimed to evaluate the effects of intramuscular administration of 5000 IU hCG on the outcomes of frozen-thawed ET in hormonal replacement cycles using a gonadotropin-releasing hormone (GnRH)-agonist protocol. Materials and Methods: This randomized controlled trial (RCT, registered April 22, 2021) was conducted at the ROYAN Institute, a tertiary referral center in Tehran, Iran, between July 2020 and August 2022. A total of 200 infertile women undergoing cleavage-stage frozen-thawed ET were enrolled. Inclusion criteria were age <40 years, body mass index <30 kg/m Results: A total of 188 participants completed the trial (93 in the intervention group and 95 in the control group). No significant differences were observed in implantation rate (P=0.903), chemical pregnancy (P=0.912), clinical pregnancy (P=0.999), pregnancy complications (P=0.480), preterm labor (P=0.853), or live birth rate (P=0.233). However, the miscarriage rate was lower in the intervention group. This reduction approached significance per cycle (P=0.059) and reached statistical significance per pregnancy (P=0.011). Conclusion: Intramuscular hCG administration in hormonal replacement cycles with a GnRH-agonist does not significantly affect overall frozen-thawed ET outcomes at the cleavage stage but may be associated with a lower miscarriage rate among those who achieve pregnancy (registration number: NCT04855383).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.